Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Correction: 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study

The Original Article was published on 21 May 2024

Correction: Trials 25, 332 (2024)

https://doi.org/10.1186/s13063-024-08102-z


Following the publication of the original article [1], we were notified that the authors would like to include the following disclosure statement:

“Dr. John Elfar holds a patent on 4-aminopyridine and has invested in startup company which intends to manufacture a pill alternative to the currently generic available pill utilized in John Elfar’s sponsored trials. Dr. Elfar served as the Chief Medical Officer at Solaxa (Solaxa.com) until October 2023 and now only serves as a founder.”

Reference

  1. Ghazi, et al. 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study. Trials. 2024;25:332. https://doi.org/10.1186/s13063-024-08102-z.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Elfar.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghazi, A., Osinski, T.L., Feng, C. et al. Correction: 4-Aminopyridine treatment for nerve injury resulting from radical retro-pubic prostatectomy: a single-center double-blind, randomized, placebo-controlled study. Trials 25, 646 (2024). https://doi.org/10.1186/s13063-024-08518-7

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13063-024-08518-7